
Lantheus Continues to Support CMS CY25 Rule for Improved Payment of Specialized Diagnostic Radiopharmaceuticals and Reaffirms PYLARIFY’s Projected Success in 2025
Lantheus Holdings, Inc. Notes Updated Payment Rates for PYLARIFY in 2025 Medicare OPPS Final Rule Introduction On November 11, 2024, Lantheus Holdings, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) have posted updated payment rates in Addendum B related to the final rule for the calendar year 2025 Medicare Hospital Outpatient Prospective…